Historique
M. CHAPPUY ;
M. NOURREDINE ;
B. CLERC ;
M. FAHMI ;
P. MISSLIN ;
M. BERTHIER ;
L. LALOI ;
B. ROLLAND
|
2022
Dans Fundamental and Clinical Pharmacology (Vol.36, n°2, April 2022) Article : Périodique
Dans Fundamental and Clinical Pharmacology (Vol.36, n°2, April 2022) Article : Périodique
BACKGROUND: Gabapentinoids (i.e., gabapentin and pregabalin) are medications approved for epilepsy, chronic pain, or generalized anxiety disorder. Recently, there have been regular reports of misuse of pregabalin, and to a lesser extent, gabapen[...]
